ASSOCIATION OF SGLT2 INHIBITORS WITH STROKE IN PATIENTS WITH TYPE 2 DIABETES: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Mi, D. [1 ]
Pan, P. [1 ]
Chen, S. [1 ]
Chen, S. [1 ]
Peng, F. [1 ]
机构：
[1] Capital Med Univ, Beijing Tiantan Hosp, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF STROKE | 2024年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
SO067 / #
引用
收藏
页码：88 / 88
页数：1
相关论文
共 50 条
  • [41] Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Milder, Tamara Y.
    Stocker, Sophie L.
    Shaheed, Christina Abdel
    McGrath-Cadell, Lucy
    Samocha-Bonet, Dorit
    Greenfield, Jerry R.
    Day, Richard O.
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (01)
  • [42] Effects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes A meta-analysis
    Zou, Cai-Yan
    Liu, Xue-Kui
    Sang, Yi-Quan
    Wang, Ben
    Liang, Jun
    MEDICINE, 2019, 98 (49)
  • [43] Effect of pharmacological selectivity of SGLT2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis
    Sayour, Alex Ali
    Olah, Attila
    Ruppert, Mihaly
    Barta, Balint Andras
    Merkely, Bela
    Radovits, Tamas
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [44] Effect of pharmacological selectivity of SGLT2 inhibitors on cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis
    Alex Ali Sayour
    Attila Oláh
    Mihály Ruppert
    Bálint András Barta
    Béla Merkely
    Tamás Radovits
    Scientific Reports, 14
  • [45] The Impact of SGLT2 Inhibitors on Dementia Onset in Patients with Type 2 Diabetes: A Meta-Analysis of Cohort Studies
    Pan, Jiani
    Yang, Huiping
    Lu, Jiatong
    Chen, Ling
    Wen, Tian
    Zhao, Shijie
    Shi, Liye
    NEUROENDOCRINOLOGY, 2025,
  • [46] The Association Between the Dosage of SGLT2 Inhibitor and Weight Reduction in Type 2 Diabetes Patients: A Meta-Analysis
    Cai, Xiaoling
    Yang, Wenjia
    Gao, Xueying
    Chen, Yifei
    Zhou, Lingli
    Zhang, Simin
    Han, Xueyao
    Ji, Linong
    OBESITY, 2018, 26 (01) : 70 - 80
  • [47] Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis
    Mainak Banerjee
    Rimesh Pal
    Satinath Mukhopadhyay
    Acta Diabetologica, 2022, 59 : 783 - 791
  • [48] Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta-analysis
    Butler, Javed
    Usman, Muhammad Shariq
    Khan, Muhammad Shahzeb
    Greene, Stephen J.
    Friede, Tim
    Vaduganathan, Muthiah
    Filippatos, Gerasimos
    Coats, Andrew J. Stewart
    Anker, Stefan D.
    ESC HEART FAILURE, 2020, 7 (06): : 3298 - 3309
  • [49] SGLT2 Inhibitors Following Acute Myocardial Infarction: A Systematic Review and Meta-Analysis
    Defante, Maria Luiza Rodrigues
    Mendes, Beatriz X.
    Queiroz, Ivo
    Mazetto, Roberto
    Barbosa, Lucas
    Romeiro, Pedro
    Antunes, Vanio
    Bulhoes, Elisio
    Silva, Catarina
    Guida, Camila
    CIRCULATION, 2024, 150
  • [50] Systematic review and meta-analysis: SGLT2 inhibitors, blood pressure and cardiovascular outcomes
    Benham, Jamie L.
    Booth, Jane E.
    Sigal, Ronald J.
    Daskalopoulou, Stella S.
    Leung, Alexander A.
    Rabi, Doreen M.
    IJC HEART & VASCULATURE, 2021, 33
12345